SCFAs are closely linked to T2DM, regulating multiple associated metabolic pathways, including modulating glucose metabolism, promoting fatty acid oxidation, and reducing inflammation, either by entering cells or by binding to cell-surface receptors like FFAR2, FFAR3, and GPR109A (Wu et al., 2023). This evidence concerns the gene CD177 and type 2 diabetes mellitus.